Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles, marking one of the largest AI partnerships in the pharma industry to date. According to ...
The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term strategy.
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...
New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with Asia.
Márcio Temtem, Hovione, discusses how his company integrates modular hardware and modeling software to accelerate pharmaceutical R&D and optimize manufacturing processes. Márcio Temtem, vice president ...
Stephen Ranjan believes teamwork is just as crucial as technology in building successful digital healthcare solutions in the pharma space Stephen Ranjan learned how to be innovative while growing up ...
Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...
When Pfizer PFE (NYSE: PFE) acquired Biohaven Pharmaceutical Holding Company Ltd., the maker of a portfolio of calcitonin gene-related peptide (CGRP) receptor antagonists such as Nurtec ODT ...
ACTO’s CxZone won the Innovation award in the AI Roleplay category for its targeted use of AI roleplay to address persistent challenges in pharmaceutical field engagement. One of the most significant ...
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving ...
Is the benefit to your medical group of maintaining ongoing relationships with pharma reps worth the cost? That’s a question confronting thousands of hospitals and medical groups today. Many factors ...